What is Infant Bacterial's market cap?

Infant Bacterial is currently worth $ 749.91 M

What kind of company is Infant Bacterial?

Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases ...

What is Infant Bacterial's official website?

Infant Bacterial's official website is http://www.ibtherapeutics.com.

What is Infant Bacterial's stock symbol?

Infant Bacterial's stock symbol is IBT.

Where is Infant Bacterial's headquarters?

Infant Bacterial is located in Sweden, Stockholms Lan.

Who are Infant Bacterial key executives?

Infant Bacterial 's key executives are Staffan Strömberg; Peter Rothschild; Erik Anders Kronström

Who are Infant Bacterial competitors?

Competitors of Infant Bacterial include Liminal BioSciences; Glycosyn

Infant Bacterial Therapeutics AB:Company Profile & Technical Research,Competitor Monitor,Market Trends - Discovery

Q: What is Infant Bacterial's industry?

Infant Bacterialis in the industry of: Pharmaceutical and Medicine Manufacturing

Q: What technical fields has Infant Bacterial researched?

Infant Bacterial has researched the technical fields related to Medicine, Drug, Gastroschisis, Enterocolitis, Gastrointestinal agent, Lactobacillus reuteri, Drug development, Breast milk, Drug discovery, Proton-pump inhibitor, Antacid, Antiemetic, Rare disease, Orphan drug

Q: What is Infant Bacterial's total number of patents?

Infant Bacterial has 11 patents in total.

Free Trial

Basic Info

Headquarter

Stockholms Lan, Sweden

Founded Year

2013

Employees

< 10

Stock Symbol

STO: IBT

Social Media

http://www.ibtherapeutics.com

Infant Bacterial is a company that provides Medicine, Drug, Gastroschisis and more. Infant Bacterial is headquartered in Sweden Stockholms Lan. Infant Bacterial was founded in 2013. Infant Bacterial has a total of 11 patents